Annual CFO
-$296.79 M
-$126.19 M-73.97%
December 31, 2023
Summary
- As of February 22, 2025, PCVX annual cash flow from operations is -$296.79 million, with the most recent change of -$126.19 million (-73.97%) on December 31, 2023.
- During the last 3 years, PCVX annual CFO has fallen by -$250.16 million (-536.51%).
- PCVX annual CFO is now -874.17% below its all-time high of -$30.47 million, reached on December 31, 2018.
Performance
PCVX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$60.71 M
+$60.69 M+49.99%
September 30, 2024
Summary
- As of February 22, 2025, PCVX quarterly cash flow from operations is -$60.71 million, with the most recent change of +$60.69 million (+49.99%) on September 30, 2024.
- Over the past year, PCVX quarterly CFO has stayed the same.
- PCVX quarterly CFO is now -561.88% below its all-time high of -$9.17 million, reached on June 30, 2020.
Performance
PCVX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$470.04 M
-$3.16 M-0.68%
September 30, 2024
Summary
- As of February 22, 2025, PCVX TTM cash flow from operations is -$470.04 million, with the most recent change of -$3.16 million (-0.68%) on September 30, 2024.
- Over the past year, PCVX TTM CFO has stayed the same.
- PCVX TTM CFO is now -4712.00% below its all-time high of -$9.77 million, reached on March 31, 2019.
Performance
PCVX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PCVX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.0% | 0.0% | 0.0% |
| 3 y3 years | -536.5% | -113.7% | -479.8% |
| 5 y5 years | -874.2% | -541.9% | -897.0% |
PCVX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -144.5% | at low | -119.2% | +61.9% | -287.2% | at low |
| 5 y | 5-year | -536.5% | at low | -561.9% | +61.9% | -917.4% | at low |
| alltime | all time | -874.2% | at low | -561.9% | +61.9% | -4712.0% | at low |
Vaxcyte Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$60.71 M(-50.0%) | -$470.04 M(+0.7%) |
| Jun 2024 | - | -$121.39 M(-23.7%) | -$466.88 M(+14.4%) |
| Mar 2024 | - | -$159.12 M(+23.5%) | -$408.22 M(+37.5%) |
| Dec 2023 | -$296.79 M(+74.0%) | -$128.81 M(+123.8%) | -$296.79 M(+27.3%) |
| Sep 2023 | - | -$57.55 M(-8.3%) | -$233.20 M(+8.9%) |
| Jun 2023 | - | -$62.74 M(+31.6%) | -$214.20 M(+12.4%) |
| Mar 2023 | - | -$47.69 M(-26.9%) | -$190.59 M(+11.7%) |
| Dec 2022 | -$170.60 M(+40.5%) | -$65.22 M(+69.2%) | -$170.60 M(+9.0%) |
| Sep 2022 | - | -$38.55 M(-1.5%) | -$156.47 M(+6.9%) |
| Jun 2022 | - | -$39.13 M(+41.2%) | -$146.34 M(+7.7%) |
| Mar 2022 | - | -$27.70 M(-45.8%) | -$135.89 M(+11.9%) |
| Dec 2021 | -$121.39 M | -$51.09 M(+79.8%) | -$121.39 M(+49.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$28.41 M(-0.9%) | -$81.07 M(+23.4%) |
| Jun 2021 | - | -$28.68 M(+117.2%) | -$65.71 M(+42.2%) |
| Mar 2021 | - | -$13.21 M(+22.6%) | -$46.20 M(-0.9%) |
| Dec 2020 | -$46.63 M(-1.1%) | -$10.77 M(-17.5%) | -$46.63 M(-7.2%) |
| Sep 2020 | - | -$13.05 M(+42.3%) | -$50.27 M(+7.7%) |
| Jun 2020 | - | -$9.17 M(-32.7%) | -$46.67 M(-8.5%) |
| Mar 2020 | - | -$13.63 M(-5.4%) | -$51.01 M(+8.2%) |
| Dec 2019 | -$47.15 M(+54.7%) | -$14.41 M(+52.3%) | -$47.15 M(+44.0%) |
| Sep 2019 | - | -$9.46 M(-30.0%) | -$32.74 M(+40.6%) |
| Jun 2019 | - | -$13.51 M(+38.3%) | -$23.28 M(+138.3%) |
| Mar 2019 | - | -$9.77 M | -$9.77 M |
| Dec 2018 | -$30.47 M | - | - |
FAQ
- What is Vaxcyte annual cash flow from operations?
- What is the all time high annual CFO for Vaxcyte?
- What is Vaxcyte annual CFO year-on-year change?
- What is Vaxcyte quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vaxcyte?
- What is Vaxcyte quarterly CFO year-on-year change?
- What is Vaxcyte TTM cash flow from operations?
- What is the all time high TTM CFO for Vaxcyte?
- What is Vaxcyte TTM CFO year-on-year change?
What is Vaxcyte annual cash flow from operations?
The current annual CFO of PCVX is -$296.79 M
What is the all time high annual CFO for Vaxcyte?
Vaxcyte all-time high annual cash flow from operations is -$30.47 M
What is Vaxcyte annual CFO year-on-year change?
Over the past year, PCVX annual cash flow from operations has changed by -$126.19 M (-73.97%)
What is Vaxcyte quarterly cash flow from operations?
The current quarterly CFO of PCVX is -$60.71 M
What is the all time high quarterly CFO for Vaxcyte?
Vaxcyte all-time high quarterly cash flow from operations is -$9.17 M
What is Vaxcyte quarterly CFO year-on-year change?
Over the past year, PCVX quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Vaxcyte TTM cash flow from operations?
The current TTM CFO of PCVX is -$470.04 M
What is the all time high TTM CFO for Vaxcyte?
Vaxcyte all-time high TTM cash flow from operations is -$9.77 M
What is Vaxcyte TTM CFO year-on-year change?
Over the past year, PCVX TTM cash flow from operations has changed by $0.00 (0.00%)